Under healthy conditions HIF-1α inhibits c-Myc activity, but in MM deregulated c-Myc becomes oncogenic and facilitates HIF-1α induced VEGF production and secretion to increase angiogenesis [79]. Here, MYC is linked to Miyoshi myopathy.